All these mutations in TGFBR2 and SMAD4 abrogate SMAD-dependent TGF-β signaling, providing evidence that dysregulated TGF-β signaling contributes to exacerbating NPC pathogenesis [89]. The gene discussed is TGFBR2; the disease is nasopharyngeal carcinoma.